- For Partners
- Science & Research
- News & Events
Global patent holder in beta-alanine sets the record straight to ensure maximum benefits
CARLSBAD, Calif. – July 11, 2017 – Natural Alternatives International, Inc. (“NAI”) (NASDAQ: NAII), the patent holder of CarnoSyn® beta-alanine, one of the leading ingredients in sports nutrition, announced today a commitment to educating consumers and manufacturers about the scientifically proven loading period and correct dosing of beta-alanine. As the sole U.S. patent holder of the ingredient, NAI has an obligation to ensure that CarnoSyn® is being taken correctly, and that consumers are reaping the muscle-building benefits.
There are more than 55 scientific studies on the benefits of beta-alanine, but in order to achieve performance benefits, it must be properly loaded and dosed. Consumers need to load a minimum of 90 grams over a period of 28 days. For advanced or maximum benefits, 179 grams over 28 days is needed. This proper dosing regimen works out to an average of 3.2-6.4 grams per day.
“It’s incredibly important that those taking CarnoSyn® beta-alanine understand that the proven benefits do not apply to them if they are under-dosing,” said Dr. Roger Harris, the biochemist who first studied the connection between beta-alanine and carnosine. “It’s up to the CarnoSyn® brand partners to formulate their supplements with the correct dose of the ingredient. Every brand partner should make a clear statement that 90-179g must be taken over a period of 28 days in order to achieve proven results.”
It’s also important to note that the maximum dose does not have to be taken all at once, consumers may stack their daily doses. This can be done in a variety of ways, including a preworkout, post-workout or stand-alone product, or as a combination. In addition to stacking and taking the proper dose, consumers must take CarnoSyn® beta-alanine every day to achieve benefits – not just on workout days.
“As the global patented supplier of CarnoSyn® beta-alanine, we’re dedicated to the science that supports our benefit claims,” said Kenneth Wolf, President of NAI, the parent company of CarnoSyn®. “But these benefits can only be supported if the end consumer is taking the product correctly. Our mission with this initiative is to lead the charge on ensuring our partners are clearly communicating the correct loading and dosing information.”
For more details visit https://www.carnosyn.com.
About Natural Alternatives International, Inc.
NAI, headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. The Company’s comprehensive partnership approach offers a wide range of innovative nutritional products and services to clients including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please visit http://www.nai-online.com.
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our future revenue profits and financial condition, our ability to maintain our patents, generate revenues from the commercialization of our patents and trademarks, secure compliance with our intellectual property rights, and develop, maintain or increase sales to new and existing customers, as well as future economic conditions and the impact of such conditions on our business. We wish to caution readers these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI’s financial performance and the forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K.
SOURCE – Natural Alternatives International, Inc.
CONTACT – Renee Michaelson, CarnoSyn® Marketing Manager, Natural Alternatives International, Inc., at 760-736-7700 or [email protected].